Wedbush Research Analysts Cut Earnings Estimates for TVTX
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Research analysts at Wedbush lowered their Q1 2025 EPS estimates for Travere Therapeutics in a report released on Monday, February 24th. Wedbush analyst L. Chico now expects that the company will post earnings of ($0.43) per share for the quarter, down from their previous estimate of ($0.42). […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Research analysts at Wedbush lowered their Q1 2025 EPS estimates for Travere Therapeutics in a report released on Monday, February 24th. Wedbush analyst L. Chico now expects that the company will post earnings of ($0.43) per share for the quarter, down from their previous estimate of ($0.42). […]
